A small hand-held biosensor is being developed by scientists to enable the easy detection of cancer. Early diagnosis and effective monitoring are two factors which are called for where cancer is ...

The electrochemical biosensor developed by Biyani and colleagues for the detection of ADAR1 in cell samples is a promising platform for monitoring cancer progression in clinical samples.

The development of ZnO-based biosensors targeting CYFRA 21-1 represents a significant advancement in cancer detection technology. With its potential for rapid, sensitive, and noninvasive screening ...

Expert Rev Mol Diagn. 2010;10(8):1069-1083. © 2010 Expert Reviews Ltd. Cite this: Ovarian cancer biomarkers for molecular biosensors and translational medicine ...

biosensors that would enable home-based health testing for supporting telemedicine. Hundreds of millions of COVID-19 tests have been conducted so far. Meanwhile, the incidence of cancer is growing ...

Future molecular assay platforms will have different types of biomarkers derived from multiple omics data, including genomics, proteomics, metabolomics, glycomics, lipidomics and toxicomics.